Back to results
US 6,284,785 B1Granted
1-arenesulfonyl-2-aryl-pyrrolidine and pyridine derivatives
AssigneeHoffmann-La Roche Inc.
InventorsVincent Mutel, Eric Vieira, Jürgen Wichmann
Life of this patent
Estimating the term…
Abstract
1-Arenesulfonyl-2-Aryl-pyrrolidine and pyridine derivatives having activity as ligands of metabotropic glutamate receptors of the formula are disclosed.
Claims44
A compound of formula I:
- wherein
- R1 signifies hydrogen, lower alkyl or hydroxy-lower alkyl;
- R2 signifies furyl, thienyl, pyridyl or phenyl, which is optionally substituted by 1 to 3 substituents, selected from lower alkyl, lower alkoxy, halogen, cyano, CF3 or —N(R4)2;
- R3 signifies naphthyl or phenyl, which is optionally substituted by 1 to 3 substituents, selected from lower alkyl, lower alkoxy, halogen, acetyl, cyano, hydroxy-lower alkyl, —CH2-morpholin-4-yl, lower alkyl-oxy-lower alkyl, lower alkyl-N(R4)2 or CF3;
- R4 signifies, independently from each other, hydrogen or lower alkyl,
- as well as their pharmaceutically acceptable salts, with the exception of
- (RS)-2-phenyl-1-(toluene-4-sulfonyl)-pyrrolidine;
- and,
- (RS)-1-(toluene-4-sulfonyl)-2-p-tolyl-pyrrolidine as well as their pharmaceutically acceptable salts.
6 more elements
Dependencies are inferred from the claim text.